1 |
Karthikeyan G, Moncur RA, Levine O, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 2009;54: 1599-606.
DOI
ScienceOn
|
2 |
Ryding AD, Kumar S, Worthington AM, Burgess D. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology 2009;111:311-9.
DOI
ScienceOn
|
3 |
Hoeks SE, Poldermans D. European Society of Cardiology 2009 guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: key messages for clinical practice. Pol Arch Med Wewn 2010;120:294-9.
|
4 |
Kim SE, Park DG, Lee JH, Han KR, Oh DJ. Utility of B-type natriuretic peptide for predicting perioperative cardiovascular events in patients without history of cardiovascular disease undergoing major non-cardiac surgery. Korean Circ J 2011;41:11-5.
DOI
ScienceOn
|